Hypoglycemic agent
Abstract
A zinc(II) complex which is lowly toxic, has high insulin-like activity, and is effectively usable as a hypoglycemic agent for the prevention or treatment of diabetes; a hypoglycemic agent containing the complex; a medicinal preparation which contains the complex and is useful as a preventive/remedy for diabetes; and a food containing the complex, such as a health food or supplementary health food. The hypoglycemic agent contains an organic zinc(II) complex having as a ligand a compound selected among aminoalkylpyridines, bis-optically active amino acids, bisaminoalkylcarboxylic acids, oligopeptides, oligopseudopeptides, di-substituted aminocarboxylic acids, α- and β-hydroxycarboxylic acids, vitamins, glutamine derivatives, etc.
Claims
exact text as granted — not AI-modified1 - 19 . (canceled).
20 . Zinc(II) organic complexes having, as a ligand, a compound of a general formula (2):
(wherein X 1 and X 2 each independently represents an alkoxy group, an amino group, a mono-lower alkylamino group, a di-lower alkylamino group, or a hydroxyl group; R and R′ each independently represents a hydrogen atom, an alkyl group, an aryl group, or an aralkyl group; R 3 and R 4 each independently represents an alkyl group, a substituted alkyl group, or a heterocyclic group; R and R 3 , and/or R1 and R 4 may be taken together to form an alkylene group; C* represents an asymmetric carbon (either (R)-form or (S)-form); and X represents an alkylene group).
21 . Zinc(II) organic complexes having, as a ligand, a compound of a general formula (3):
(wherein X 1 and X 2 each independently represents an alkoxy group, an amino group, a mono-lower alkylamino group, a di-lower alkylamino group, or a hydroxyl group; R and R′ each independently represents a hydrogen atom, an alkyl group, an aryl group, or an aralkyl group; X represents an alkylene group; n indicates an integer of from 1 to 3).
22 . Zinc(II) organic complexes having, as a ligand, a compound of a general formula (4) (when it is an optically-active compound, it contains both (R)-form and (S)-form thereof):
(wherein X 1 represents an alkoxy group, an amino group, a mono-lower alkylamino group, a di-lower alkylamino group, or a hydroxyl group; R, R′ and R″ each independently represents a hydrogen atom, an alkyl group, an aryl group, or an aralkyl group; R 3′ and Ro 3 each independently represents a hydrogen atom, an alkyl group, a substituted alkyl group, or a heterocyclic group; R and R 3′ , and/or R″ and R o 3 may be taken together to form an alkylene group; n indicates an integer of from 1 to 3).
23 . Zinc(II) organic complexes having, as a ligand, a compound of a general formula (5) (when it is an optically-active compound, it contains both (R)-form and (S)-form thereof):
(wherein X 1 represents an alkoxy group, an amino group, a mono-lower alkylamino group, a di-lower alkylamino group, or a hydroxyl group; R and R′ each independently represents a hydrogen atom, an alkyl group, an aryl group, or an aralkyl group; R 3 ′, R 4 ″ and R 5 each independently represents a hydrogen atom, an alkyl group, a substituted alkyl group, or a heterocyclic group; R and R 3′ may be taken together to form an alkylene group; n indicates an integer of from 1 to 3).
24 . Zinc(II) organic complexes having, as a ligand, a compound of a general formula (6) (when it is an optically-active compound, it contains both (R)-form and (S)-form thereof):
[wherein X 1 represents an alkoxy group, an amino group, a mono-lower alkylamino group, a di-lower alkylamino group, or a hydroxyl group; R represents a hydrogen atom, an alkyl group, a substituted alkyl group, or a heterocyclic group; R 6 and R 7 each independently represents an alkyl group, an aralkyl group, or a group of the following formula (6′):
(wherein R 8 and R 9 each independently represents a hydrogen atom, an alkyl group, a nitro group, or a halogen atom); R 6 and R 3 may be taken together to form an alkylene group]
25 . Zinc(II) organic complexes having, as a ligand, a compound of a general formula (9):
[wherein R 10 and R 11 each independently represents a hydrogen atom, an alkyl group, a hydroxyalkyl group, (CH 2 ) m NRR′, (CH2) m N + RR′R″, —(CH2) m SR, —(CH 2 ) m S + RR′, —(CH 2 ) n COOR or —(CH 2 ) n CONRR′ (where m indicates an integer of from 0 to 4; and R, R′ and R″ each independently represents a hydrogen atom, an alkyl group, an aryl group, or an aralkyl group)].
26 . Zinc(II) organic complexes having, as a ligand, a compound of a general formula (10):
27 . Zinc(II) organic complexes having, as a ligand, a compound of a general formula (11):
(wherein X 0 − ; represents Cl − , Br − or I − ).
28 . Zinc(II) organic complexes having, as a ligand, a compound of a general formula (12):
(wherein R −12 and R 13 each independently represents an alkyl group, an aryl group, or an aralkyl group).
29 . A food that contains a zinc(II) organic complex having, as a ligand, any of L-lactic acid, quinic acid, L-carnitine (vitamin B T ), vitamin C, vitamin U or L-theanine.
30 . The food according to claim 29 wherein said food is a health food or a supplementary health food.Join the waitlist — get patent alerts
Track US2005130880A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.